Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220008225 220003299 1.83 92.85 Curative (C) 2014-05-06 2014-05-06 Cytarabine High Dose N N 220034081 CYTARABINE HIGH DOSE
220008226 220003300 1.8 86.7 Palliative (P) 2018-01-17 2018-01-17 RAVVA TRIAL 02 N 220034084 PEMBROLIZUMAB
220008227 220003300 1.54 69.4 Palliative (P) 2016-04-08 2016-04-25 Rituximab 2 N 220034084 RITUXIMAB
220008228 220003300 1.61 99.2 Curative (C) 2014-03-02 2014-03-03 Gemcitabine 1000mg/m2 D1 8 15 2 Y 220034084 RITUXIMAB
220008229 220003300 1.86 67.7 Palliative (P) 2016-05-02 2016-05-22 Carboplatin + Etoposide IV 3 day N N 220034084 CARBOPLATIN + ETOPOSIDE
220008230 220003300 1.78 null null 2017-03-17 2017-03-24 Carboplatin + Etoposide iv&po null null 220034084 CARBOPLATIN + ETOPOSIDE
220008231 220003300 1.78 76 Palliative (P) 2013-07-15 2013-07-15 GEMCITABINE 1 N 220034084 RAVVA TRIAL
220008232 220003300 1.7 null Curative (C) 2017-07-21 2017-07-22 ALEMTUZUMAB + FLUDARABINE + MELPHALAN N N 220034084 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220008233 220022026 1.8 102 Curative (C) 2018-07-02 2018-10-01 Cytarabine High Dose 2 N 220034094 CYTARABINE HIGH DOSE
220008234 220003301 1.89 null Palliative (P) 2014-03-30 2014-04-14 EOX 02 Y 220034100 EOX
220008235 220003301 1.55 89 Palliative (P) 2015-10-30 2015-11-03 EOX N N 220034100 EOX
220008236 220003301 1.77 63.8 Curative (C) 2017-03-05 2017-03-10 FLAG 02 Y 220034100 FLAG
220008237 220003301 1.73 80.2 Curative (C) 2015-07-01 2015-07-01 FLAG N N 220034100 FLAG
220008238 220003301 0 80 Palliative (P) 2014-01-24 2014-01-27 RAVVA TRIAL 02 N 220034100 RITUXIMAB
220008239 220003301 null 80 null 2015-07-16 2015-07-23 PEMBROLIZUMAB N null 220034100 RAVVA TRIAL
220008240 220003302 1.59 63 Palliative (P) 2016-04-26 2016-05-12 EOX N N 220034109 EOX
220008241 220003303 1.8 102.4 Curative (C) 2016-09-26 2016-09-28 Cytarabine High Dose N N 220034115 CYTARABINE HIGH DOSE
220008242 220003303 1.57 59 Palliative (P) 2014-03-01 2014-03-01 EOX N N 220034115 EOX
220008243 220003303 null 67.7 Curative (C) 2013-05-07 2013-05-12 AML Int Guide ADE 8+3+5 (2) 02 null 220034115 ADE
220008244 220003303 null 100 Disease modification (D) 2017-01-25 2017-01-30 PEMBROLIZUMAB N null 220034115 RITUXIMAB
220008245 220003303 1.75 81 Palliative (P) 2014-07-30 2014-07-31 ECX N N 220034115 ECX
220008246 220003304 null 53.7 Palliative (P) 2013-03-28 2013-03-28 EOX N N 220034124 EOX
220008247 220003305 1.81 70 Palliative (P) 2017-12-01 2017-12-01 RAVVA TRIAL 02 N 220034127 GEMCITABINE
220008248 220003305 0 60 Curative (C) null 2017-03-03 Cytarabine High Dose N N 220034127 CYTARABINE HIGH DOSE
220008249 220016364 null 31.9 null null 2017-12-14 CAPECITABINE + OXALIPLATIN N N 220034132 CAPECITABINE + OXALIPLATIN
220008250 220003306 null 69 Palliative (P) 2016-02-12 2016-02-12 Carboplatin + Etoposide IV 3 day null N 220034133 CARBOPLATIN + ETOPOSIDE
220008251 220003307 1.75 110 Palliative (P) 2013-05-23 2013-05-28 ECX 2 null 220034134 ECX
220008254 220016365 1.86 80.2 Adjuvant (A) 2013-07-18 2013-07-22 Alemtuz+Fludara+Melphalan RIC MUD N N 220034137 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220008255 220016365 1.8 105.6 Palliative (P) 2017-05-03 2017-05-03 EOX 02 N 220034137 EOX
220008256 220016365 1.65 62 Palliative (P) 2016-04-04 2016-04-04 CARBOPLATIN + ETOPOSIDE N N 220034137 CARBOPLATIN + ETOPOSIDE
220008257 220016365 1.73 72.2 Curative (C) 2013-08-20 2013-08-21 FLAG Y null 220034137 FLAG
220008258 220016365 1.68 86 Not known (9) 2014-01-04 2014-01-04 Gemcitabine weekly N N 220034137 RITUXIMAB
220008259 220016365 1.67 71.1 Palliative (P) 2014-03-25 2014-03-31 Oxaliplatin + Modified de Gramont N N 220034137 OXALIPLATIN + MDG
220008260 220016365 1.78 82 Curative (C) 2015-08-11 2015-11-03 Cytarabine High Dose N N 220034137 CYTARABINE HIGH DOSE
220008261 220003309 null 61.1 Not known (9) 2014-04-08 2014-04-14 Carboplatin AUC 2 - 5 null null 220034152 CARBOPLATIN
220008262 220003310 1.7 110 Curative (C) 2014-11-07 2014-11-07 AML Int Guide ADE 10+3+5 (1) N N 220034155 ADE
220008263 220003311 1.77 74 Curative (C) 2015-08-28 2015-08-28 Alemtuz+Fludara+Melphalan RIC MUD N N 220034156 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220008264 220011826 null 70.4 Palliative (P) 2016-08-27 2016-09-10 PEMBROLIZUMAB N N 220034158 PEMBROLIZUMAB
220008265 220003312 1.66 69.6 Adjuvant (A) 2017-01-07 2017-01-09 Cisplatin + Radiotherapy + CISPLATIN N N 220034159 CISPLATIN + RT
220008266 220003312 null 23.1 Curative (C) 2013-01-21 2013-01-26 FLAG N N 220034159 FLAG
220008267 220016366 1.65 82 Palliative (P) null 2017-07-13 ECX 02 N 220034163 ECX
220008268 220003313 1.81 69.6 Curative (C) 2017-11-08 2017-11-09 AML Int Guide ADE 10+3+5 (1) N N 220034164 ADE
220008272 220018970 null 74 Palliative (P) 2017-10-29 2017-10-30 Gemcitabine 1000mg/m2 D1 8 15 Y N 220034174 RITUXIMAB
220008273 220018970 1.57 68 Palliative (P) 2017-05-15 2017-05-15 ECX 02 N 220034174 ECX
220008274 220003315 null 68.7 Disease modification (D) 2014-09-27 2014-09-28 PEMBROLIZUMAB null null 220034180 GEMCITABINE
220008275 220003316 1.89 66.6 Palliative (P) 2017-04-11 2017-04-11 Carboplatin AUC 2 - 5 N null 220034182 CARBOPLATIN
220008276 220003317 1.61 59.3 Palliative (P) 2016-10-22 2016-10-26 EOX 02 N 220034187 EOX
220008277 220003318 null 13.4 null 2018-04-15 2018-04-15 RAVVA TRIAL null null 220034189 RITUXIMAB
220008278 220003318 1.48 52 Curative (C) 2017-02-01 2017-02-01 Cisplatin 100 + RT(H&N) 1 day 02 N 220034189 CISPLATIN + RT
220008279 220003318 1.74 99 Palliative (P) 2018-07-12 2018-07-13 Gemcitabine weekly 02 N 220034189 GEMCITABINE